NHG-Richtlijnen
NHG-Standaard
M33
4.1
januari 2014
mei 2024
R. Luchtwegen

Richtlijnen diagnostiek

Naar Volledige tekst ›

Anamnese

Naar Volledige tekst ›

Lichamelijk onderzoek

Naar Volledige tekst ›

Aanvullend onderzoek

Naar Volledige tekst ›

Evaluatie

Naar Volledige tekst ›

Richtlijnen beleid

Naar Volledige tekst ›

Voorlichting

Naar Volledige tekst ›

Niet-medicamenteuze behandeling

Naar Volledige tekst ›

Medicamenteuze behandeling

Naar Volledige tekst ›

Controles

Naar Volledige tekst ›

Consultatie en verwijzing

Naar Volledige tekst ›

Belangrijkste wijzigingen

Naar Samenvatting ›

Kernboodschappen

Naar Samenvatting ›

Inleiding

Naar Samenvatting ›

Scope

Naar Samenvatting ›

Buiten de scope

Naar Samenvatting ›

Achtergronden

Naar Samenvatting ›

Begrippen

Naar Samenvatting ›

Acute rhinosinusitis

Naar Samenvatting ›

Epidemiologie

Naar Samenvatting ›

Etiologie en pathofysiologie

Naar Samenvatting ›

Mogelijk faciliterende factoren

Naar Samenvatting ›

Natuurlijk beloop

Naar Samenvatting ›

Richtlijnen diagnostiek

Naar Samenvatting ›

Anamnese

Naar Samenvatting ›

Alarmsymptomen

Naar Samenvatting ›

Telefonische beoordeling

Naar Samenvatting ›

Lichamelijk onderzoek

Naar Samenvatting ›

Aanvullend onderzoek

Naar Samenvatting ›

Evaluatie

Naar Samenvatting ›

Differentiaaldiagnosen

Naar Samenvatting ›

Richtlijnen beleid

Naar Samenvatting ›

Voorlichting en advies

Naar Samenvatting ›

Geen antibiotica bij ongecompliceerde rhinosinusitis

Naar Samenvatting ›

Astma

Naar Samenvatting ›

Controles

Naar Samenvatting ›

Thuisarts

Naar Samenvatting ›

Niet-medicamenteuze behandeling

Naar Samenvatting ›

(Fysiologische) zoutoplossing

Naar Samenvatting ›

Stomen

Naar Samenvatting ›

Medicamenteuze behandeling

Naar Samenvatting ›

Symptoombestrijding

Naar Samenvatting ›

Antibiotica

Naar Samenvatting ›
Overwegingen bij antibiotica
Naar Samenvatting ›
Keuze antibioticum
Naar Samenvatting ›
Geen verbetering 2 dagen na start antibioticum
Naar Samenvatting ›
Doseringen antibiotica
Naar Samenvatting ›

Intranasale corticosteroïden

Naar Samenvatting ›

Controles

Naar Samenvatting ›

Consultatie en verwijzing

Naar Samenvatting ›

Consultatie

Naar Samenvatting ›

Verwijzing

Naar Samenvatting ›

Referenties

  1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012;3-298.
  2. CKS. Diagnosis of acute sinusitis (2009).
  3. KNO, Kwaliteitsinstituut voor de gezondheidszorg CBO. Richtlijn chronische rhinosinusitis en neuspoliepen (2010). Ga naar bron
  4. Lang J. Development of the paranasal sinuses. Clinical anatomy of the head: neurocranium, orbit, craniocervical regions. Berlin/Heidelberg/New York: Springer, 1983.
  5. NIVEL. Incidentie en prevalentie van Acute/chronische sinusitis in de Nederlandse huisartsenpraktijk naar leeftijd en geslacht (per 1000 patiëntjaren) (2012a) Ga naar bron
  6. NIVEL. Incidentie en prevalentie van Symptomen/klachten sinussen (inclusief pijn) in de Nederlandse huisartsenpraktijk naar leeftijd en geslacht (per 1000 patiëntjaren) (2012b). Ga naar bron
  7. Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 2003;113:1199-205.
  8. SIG. [Schriftelijke mededeling]. Utrecht: Stichting Informatiecentrum Gezondheidszorg, 1996.
  9. Clayman GL, Adams GL, Paugh DR, Koopmann CF Jr. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope 1991;101:234-9.
  10. Hansen FS, Hoffmans R, Georgalas C, Fokkens WJ. Complications of acute rhinosinusitis in The Netherlands. Fam Pract 2012;29:147-53.
  11. Lindbaek M, Hjortdahl P, Johnsen UL. Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ 1996a;313:325-9.
  12. Van Cauwenberge P, Ingels K. Effects of viral and bacterial infection on nasal and sinus mucosa. Acta Otolaryngol 1996;116:316-21.
  13. Drettner B. Pathophysiology of paranasal sinuses with clinical implications. Clin Otolaryngol 1980;5:277-84.
  14. Van Buchem FL, Peeters MF, Beaumont J, Knottnerus JA. Acute maxillary sinusitis in general practice: the relation between clinical picture and objective findings. Eur J Gen Pract 1995;1:155-60.
  15. Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995;311:233-6.
  16. Payne SC, Benninger MS. Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis. Clin Infect Dis 2007;45:e121-e127.
  17. Ambati BK, Ambati J, Azar N, Stratton L, Schmidt EV. Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. Ophthalmology 2000;107:1450-3.
  18. Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe--an underestimated disease. A GA(2)LEN study. Allergy 2011;66:1216-23.
  19. Mahakit P, Pumhirun P. A preliminary study of nasal mucociliary clearance in smokers, sinusitis and allergic rhinitis patients. Asian Pac J Allergy Immunol 1995;13:119-21.
  20. Sobol SE, Frenkiel S, Nachtigal D, Wiener D, Teblum C. Clinical manifestations of sinonasal pathology during pregnancy. J Otolaryngol 2001;30:24-8.
  21. Gwaltney JM Jr., Hendley JO, Phillips CD, Bass CR, Mygind N, Winther B. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 2000;30:387-91.
  22. Davenport NA. Predictors of barotrauma events in a Navy altitude chamber. Aviat Space Environ Med 1997;68:61-5.
  23. Parell GJ, Becker GD. Neurological consequences of scuba diving with chronic sinusitis. Laryngoscope 2000;110:1358-60.
  24. Ishikawa Y, Kawano M, Honjo I, Amitani R. The cause of nasal sinusitis in patients with cleft palate. Arch Otolaryngol Head Neck Surg 1989;115:442-6.
  25. Rosenfeld RM, Singer M, Jones S. Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngol Head Neck Surg 2007;137:S32-S45.
  26. Lemiengre MB, Van Driel ML, Merenstein D, Young J, De Sutter AI. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev 2012;10:CD006089.
  27. Young J, De Sutter A, Merenstein D, Van Essen GA, Kaiser L, Varonen H, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet 2008;371:908-14.
  28. Van Duijn NP. Sinusitis maxillaris: symptomen, beloop en diagnostiek [proefschrift]. Lelystad: Meditekst, 1991.
  29. Cronin MJ, Khan S, Saeed S. The role of antibiotics in the treatment of acute rhinosinusitis in children: a systematic review. Arch Dis Child 2013;98:299-303.
  30. Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children: a double-blind, placebo-controlled trial. Pediatrics 1986;77:795-800.
  31. Garbutt JM, Goldstein M, Gellman E, Shannon W, Littenberg B. A randomised, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics 2001;107:619-25.
  32. Kristo A, Uhari M, Luotonen J, Ilkko E, Koivunen P, Alho OP. Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. Acta Paediatr 2005;94:1208-13.
  33. Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics 2009;124:9-15.
  34. CVZ. Farmacotherapeutisch kompas 2013. Amstelveen: College voor Zorgverzekeringen, 2013a.
  35. García-Rodríguez JF, Corominas M, Fernandez-Viladrich P, Monfort JL, Dicenta M. Rhinosinusitis and atopy in patients infected with HIV. Laryngoscope 1999;109:939-44.
  36. Gurney TA, Lee KC, Murr AH. Contemporary issues in rhinosinusitis and HIV-infection. Curr Opin Otolaryngol Head Neck Surg 2003;11:45-8.
  37. Rubin JS, Honigber R. Sinusitis in patients with the acquired immunodeficiency syndrome. Ear Nose Throat J 1990;89:460-3.
  38. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America (2014). Ga naar bron
  39. NVHB. Richtlijn HIV (2014). Nederlandse vereniging van hiv-behandelaren. Ga naar bron
  40. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281-8.
  41. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003;26:510-3.
  42. Bartelink ML, Hoek L, Freriks JP, Rutten GE. Infections in patients with type 2 diabetes in general practice. Diabetes Res Clin Pract 1998;40:15-9.
  43. Jones NS, Walker JL, Bassi S, Jones T, Punt J. The intracranial complications of rhinosinusitis: can they be prevented? Laryngoscope 2002;112:59-63.
  44. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol 1988;105:343-9.
  45. Hansen JG, Hojbjerg T, Rosborg J. Symptoms and signs in culture-proven acute maxillary sinusitis in a general practice population. APMIS 2009;117:724-9.
  46. Hansen JG, Lund E. The association between paranasal computerized tomography scans and symptoms and signs in a general practice population with acute maxillary sinusitis. APMIS 2011;119:44-8.
  47. Hirshoren N, Hirschenbein A, Eliashar R. Risk stratification of severe acute rhinosinusitis unresponsive to oral antibiotics. Acta Otolaryngol 2010;130:1065-9.
  48. Lindbaek M, Hjortdahl P, Johnsen UL. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: comparison with computed tomography. Fam Med 1996b;28:183-8.
  49. Young J, Bucher H, Tschudi P, Periat P, Hugenschmidt C, Welge-Lussen A. The clinical diagnosis of acute bacterial rhinosinusitis in general practice and its therapeutic consequences. J Clin Epidemiol 2003;56:377-84.
  50. Bjerrum L, Gahrn-Hansen B, Munck AP. C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 2004;54:659-62.
  51. Cals JW, Schot MJ, De Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med 2010;8:124-33.
  52. Llor C, Bjerrum L, Arranz J, Garcia G, Cots JM, Gonzalez Lopez-Valcarcel B, et al. C-reactive protein testing in patients with acute rhinosinusitis leads to a reduction in antibiotic use. Fam Pract 2012;29:653-8.
  53. Engels EA, Terrin N, Barza M, Lau J. Meta-analysis of diagnostic tests for acute sinusitis. J Clin Epidemiol 2000;53:852-62.
  54. Varonen H, Makela M, Savolainen S, Laara E, Hilden J. Comparison of ultrasound, radiography, and clinical examination in the diagnosis of acute maxillary sinusitis: a systematic review. J Clin Epidemiol 2000;53:940-8.
  55. Lindbaek M, Hjortdahl P. The clinical diagnosis of acute purulent sinusitis in general practice--a review. Br J Gen Pract 2002;52:491-5.
  56. Venekamp RP, Bonten MJ, Rovers MM, Verheij TJ, Sachs AP. Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomized controlled trial. CMAJ 2012a;184:E751-E757.
  57. Hoffmans R, Schermer T, Van Weel C, Fokkens W. Management of rhinosinusitis in Dutch general practice. Prim Care Respir J 2011;20:64-70.
  58. Akkerman AE, Kuyvenhoven MM, Van der Wouden JC, Verheij TJ. Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother 2005;56:930-6.
  59. Dosh SA, Hickner JM, Mainous AG III, Ebell MH. Predictors of antibiotic prescribing for nonspecific upper respiratory infections, acute bronchitis, and acute sinusitis. An UPRNet study. Upper Peninsula Research Network. J Fam Pract 2000;49:407-14.
  60. Cockburn J, Pit S. Prescribing behaviour in clinical practice: patients’ expectations and doctors’ perceptions of patients’ expectations--a questionnaire study. BMJ 1997;315:520-3.
  61. Macfarlane J, Prewett J, Rose D, Gard P, Cunningham R, Saikku P, et al. Prospective case-control study of role of infection in patients who reconsult after initial antibiotic treatment for lower respiratory tract infection in primary care. BMJ 1997;315:1206-10.
  62. Hong JS, Philbrick JT, Schorling JB. Treatment of upper respiratory infections: do patients really want antibiotics? Am J Med 1999;107:511-5.
  63. Welschen I, Kuyvenhoven M, Hoes A, Verheij T. Antibiotics for acute respiratory tract symptoms: patients’ expectations, GPs’ management and patient satisfaction. Fam Pract 2004;21:234-7.
  64. Van Duijn HJ, Kuyvenhoven MM, Schellevis FG, Verheij TJ. Illness behaviour and antibiotic prescription in patients with respiratory tract symptoms. Br J Gen Pract 2007;57:561-8.
  65. Smith SR, Montgomery LG, Williams JW Jr. Treatment of mild to moderate sinusitis. Arch Intern Med 2012;172:510-3.
  66. Kaper NM, Breukel L, Venekamp RP, Grolman W, Van der Heijden GJ. Absence of evidence for enhanced benefit of antibiotic therapy on recurrent acute rhinosinusitis episodes: A systematic review of the evidence base. Otolaryngol Head Neck Surg 2013;149:664-7.
  67. Blin P, Blazejewski S, Lignot S, Lassalle R, Bernard MA, Jayles D, et al. Effectiveness of antibiotics for acute sinusitis in real-life medical practice. Br J Clin Pharmacol 2010;70:418-28.
  68. Jani AL, Hamilos DL. Current thinking on the relationship between rhinosinusitis and asthma. J Asthma 2005;42:1-7.
  69. Hak E, Rovers MM, Sachs AP, Stalman WA, Verheij TJ. Is asthma in 2-12 year-old children associated with physician-attended recurrent upper respiratory tract infections? Eur J Epidemiol 2003;18:899-902.
  70. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-6.
  71. Shaikh N, Wald ER, Pi M. Decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Cochrane Database Syst Rev 2012;9:CD007909.
  72. Kassel JC, King D, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2010;CD006821.
  73. Wang YH, Ku MS, Sun HL, Lue KH. Efficacy of nasal irrigation in the treatment of acute sinusitis in atopic children. J Microbiol Immunol Infect 2012;47:63-9.
  74. Hildenbrand T, Weber R, Heubach C, Mosges R. Nasenspülungen bei akuter Rhinosinusitis. Laryngorhinootologie 2011;90:346-51.
  75. Khianey R, Oppenheimer J. Is nasal saline irrigation all it is cracked up to be? Ann Allergy Asthma Immunol 2012;109:20-8.
  76. Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev 2004;CD001728.
  77. Kerkhof E, Nieuwenhuis MK, Vloemans AFPM, Dokter J, Baartmans MGA. Stoominhalatietherapie: ineffectief en gevaarlijk! Ernstige brandwonden bij kinderen als complicatie van stoominhalatietherapie (2010). WCS Kenniscentrum Wondzorg. Ga naar bron
  78. Dunn C, Gauthier M, Gaudreault P. Coma in a neonate following single intranasal dose of xylometazoline. Eur J Pediatr 1993;152:541.
  79. Higgins GL III, Campbell B, Wallace K, Talbot S. Pediatric poisoning from over-the-counter imidazoline-containing products. Ann Emerg Med 1991;20:655-8.
  80. Mahieu LM, Rooman RP, Goossens E. Imidazoline intoxication in children. Eur J Pediatr 1993;152:944-6.
  81. Soderman P, Sahlberg D, Wiholm BE. CNS reactions to nose drops in small children. Lancet 1984;1:573.
  82. Van Velzen AG, Van Riel AJ, Hunault C, Van Riemsdijk TE, De Vries I, Meulenbelt J. A case series of xylometazoline overdose in children. Clin Toxicol (Phila) 2007;45:290-4.
  83. FDA. Public health advisory: FDA recommends that over-the-counter (OTC) cough and cold products not be used for infants and children under 2 years of age (2013). U.S. Department of health and human services. FDA U.S food and drug administration. Ga naar bron
  84. Sen EF, Verhamme KM, Felisi M, ‘t Jong GW, Giaquinto C, Picelli G, et al. Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age. Br J Clin Pharmacol 2011;71:943-50.
  85. Sederberg-Olsen JF, Sederberg-Olsen AE. Intranasal sodium cromoglycate in post-catarrhal hyperreactive rhinosinusitis: a double-blind placebo controlled trial. Rhinology 1989;27:251-5.
  86. Butler CC, Robling M, Prout H, Hood K, Kinnersley P. Management of suspected acute viral upper respiratory tract infection in children with intranasal sodium cromoglicate: a randomised controlled trial. Lancet 2002;359:2153-8.
  87. De Sutter AI, Van Driel ML, Kumar AA, Lesslar O, Skrt A. Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst Rev 2012;2:CD004976.
  88. CDC. Cough and cold medication (2007). Ga naar bron
  89. Chonmaitree T, Saeed K, Uchida T, Heikkinen T, Baldwin CD, Freeman DH Jr., et al. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr 2003;143:377-85.
  90. Shefrin AE, Goldman RD. Use of over-the-counter cough and cold medications in children. Can Fam Physician 2009;55:1081-3.
  91. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, Varonen H, Rautakorpi UM, Williams JW, Jr., et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2011;CD000243.
  92. NVMM, RIVM. Infectieziekten Surveillance Informatie Systeem-Antibiotica Resistentie (ISIS-AR) (2013). Ga naar bron
  93. Grayson ML, Kucers A, Crowe S, McCarthy J, Mills J, Mouton J, et al. Kucers’ the use of antibiotics: a clinical review of antibacterial antifungal and antiviral drugs. Oxford, U.K.: Taylor & Francis Ltd, 2010.
  94. Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol 2009;67:161-71.
  95. Keith PK, Dymek A, Pfaar O, Fokkens W, Yun KS, Wu W, et al. Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study. Prim Care Respir J 2012;21:267-75.
  96. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005;116:1289-95.
  97. Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA 2007;298:2487-96.
  98. Barlan IB, Erkan E, Bakir M, Berrak S, Basaran MM. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 1997;78:598-601.
  99. Nayak AS, Settipane GA, Pedinoff A, Charous BL, Meltzer EO, Busse WW, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol 2002;89:271-8.
  100. Van Loon JW, Van Harn RP, Venekamp RP, Kaper NM, Sachs AP, Van der Heijden GJ. Limited Evidence for Effects of intranasal corticosteroids on symptom relief for recurrent acute rhinosinusitis. Otolaryngol Head Neck Surg 2013;149:668-73.
  101. Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev 2011;CD009274.
  102. CVZ. Informatie over geneesmiddelenkosten (2013).2013b. Ga naar bron
  103. Venekamp RP, Rovers MM, Verheij TJ, Bonten MJ, Sachs AP. Treatment of acute rhinosinusitis: discrepancy between guideline recommendations and clinical practice. Fam Pract 2012b;29:706-12.
  104. Venekamp RP, Thompson MJ, Hayward G, Heneghan CJ, Del Mar CB, Perera R, et al. Systemic corticosteroids for acute sinusitis. Cochrane Database Syst Rev 2014;CD008115.
NHG-werkgroep:
Venekamp RP, De Sutter A, Sachs A, Bons SCS, Wiersma Tj, De Jongh E
5 gerelateerde lacunes
E-mail